PPD Expands Vaccine Development Laboratory
PTSM: Pharmaceutical Technology Sourcing and Management
Increased capacity at PPD’s Richmond, VA laboratory are designed to support customers’ vaccine development programs.
Pharmaceutical Product Development, LLC (PPD), announced on May 18, 2017 the expansion of its vaccine sciences lab in Richmond, VA. The new vaccines laboratory space features 17,000 square feet for vaccine efficacy testing using cell-based assays and immunochemistry.
The lab offers services that support vaccine development including method development, qualification, and validation; extensive statistical and regulatory expertise; and high-throughput, automated and/or multiplex assays. The lab has diverse experience with multiple assay formats, including molecular genomics, immunology, cell-based and functional assays, the company reports.
In recent years, the facility has added about 50,000 sq. ft. and now totals nearly 200,000 sq. ft. Improvements at the laboratory include enhancements to genomics, immunochemistry, and automation services. The facility employ nearly 700 people, including doctorate-level scientists, analytical laboratory staff. and other scientific professionals.
Source: PPD
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Intertek to Expand UK GMP Facility with 6000 Square Feet of Lab and Office Space
May 7th 2025The company said the expansion is in response to globally rising demand for inhaled biologics, which offer distinct advantages in route of administration, but can be challenging products for developers.
